Sofwave Medical LTD announced it has received approval from the Korean Ministry of Foods and Drug Safety to market Sofwave™ its proprietary next-generation Synchronous Ultrasound Parallel Beam technology SUPERB™ for reducing the appearance of fine lines and wrinkles while also revitalizing the skin. Sofwave's Synchronous Ultrasound Parallel Beam technology SUPERB™ addresses the growing demand for non-invasive treatments that deliver noticeable wrinkle reduction. The device's seven cooled transducers are directly coupled to the epidermis, creating a unique 3D array of volumetric thermal zones that deliver parallel energy simultaneously, heating precisely at the right depth in the mid-dermis to improve the overall appearance. A single Sofwave treatment reduces facial wrinkles in a fast 30 to 45 minute non-invasive treatment with no interruption to a patient's daily routine or post-treatment discomfort.